ANAVEX LIFE SCIENCES CORP. Earnings Per Share (Diluted)
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Earnings Per Share (Diluted) of $0.08 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for the quarter ending 2026-06-30 was $0.08.
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.06.
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.06.
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for the quarter ending 2025-09-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for fiscal 2025 was -$0.54.
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for fiscal 2024 was -$0.52.
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for fiscal 2023 was -$0.60.
- ANAVEX LIFE SCIENCES CORP. earnings per share, diluted for fiscal 2022 was -$0.62.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.08 10-Q · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.03 10-Q · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2026-03-31 | -$0.06 10-Q · filed 2026-08-28 | -$0.12 10-Q · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-12-31 | -$0.06 10-Q · filed 2026-02-09 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-09-30 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.54 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | -$0.16 10-Q · filed 2026-08-28 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.43 10-Q · filed 2026-08-28 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-03-31 | -$0.13 10-Q · filed 2026-08-28 | -$0.27 10-Q · filed 2026-08-28 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2024-12-31 | -$0.14 10-Q · filed 2026-02-09 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2024-09-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.52 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | -$0.14 10-Q · filed 2025-08-12 | -$0.27 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$0.38 10-Q · filed 2025-08-12 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2024-03-31 | -$0.13 10-Q · filed 2025-05-13 | -$0.23 10-Q · filed 2025-05-13 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2023-12-31 | -$0.11 10-Q · filed 2025-02-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2023-09-30 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.60 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | -$0.14 10-Q · filed 2024-08-06 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$0.47 10-Q · filed 2024-08-06 | |||||
| 2023-03-31 | -$0.17 10-Q · filed 2024-05-09 | -$0.33 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | -$0.17 10-Q · filed 2024-02-07 | |||||||
| 2022-09-30 | -$0.62 10-K · filed 2023-11-27 | |||||||
| 2021-09-30 | -$0.54 10-K · filed 2023-11-27 | |||||||
| 2017-03-31 | -$0.04 10-Q · filed 2017-05-10 | -$0.12 10-Q · filed 2017-05-10 | -$0.29 derived: net income ÷ weighted average shares · filed 2019-01-25 | -$0.36 derived: net income ÷ weighted average shares · filed 2019-01-25 | ||||
| 2016-12-31 | -$0.08 10-Q · filed 2017-02-07 | -$0.26 derived: net income ÷ weighted average shares · filed 2019-01-25 | -$0.32 derived: net income ÷ weighted average shares · filed 2019-01-25 | -$0.38 derived: net income ÷ weighted average shares · filed 2019-01-25 | ||||
| 2016-09-30 | -$0.18 derived: net income ÷ weighted average shares · filed 2019-01-25 | -$0.25 derived: net income ÷ weighted average shares · filed 2019-01-25 | -$0.30 derived: net income ÷ weighted average shares · filed 2019-01-25 | -$0.42 10-K · filed 2016-12-14 | ||||
| 2016-06-30 | -$0.06 10-Q · filed 2016-08-11 | -$0.12 derived: net income ÷ weighted average shares · filed 2017-08-07 | -$0.24 10-Q · filed 2016-08-11 | -$0.41 derived: net income ÷ weighted average shares · filed 2017-12-11 | ||||
| 2016-03-31 | -$0.06 10-Q · filed 2017-05-10 | -$0.17 10-Q · filed 2017-05-10 | -$0.35 derived: net income ÷ weighted average shares · filed 2017-12-11 | -$0.54 derived: net income ÷ weighted average shares · filed 2017-12-11 | ||||
| 2015-12-31 | -$0.12 10-Q · filed 2017-02-07 | -$0.30 derived: net income ÷ weighted average shares · filed 2017-12-11 | -$0.50 derived: net income ÷ weighted average shares · filed 2017-12-11 | -$0.64 derived: net income ÷ weighted average shares · filed 2017-12-11 | ||||
| 2015-09-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2017-12-11 | -$0.41 derived: net income ÷ weighted average shares · filed 2017-12-11 | -$0.55 derived: net income ÷ weighted average shares · filed 2017-12-11 | -$0.65 10-K · filed 2016-12-14 | ||||
| 2015-06-30 | -$0.22 10-Q · filed 2016-08-11 | -$0.06 10-Q · filed 2015-08-14 | -$0.36 derived: net income ÷ weighted average shares · filed 2016-08-11 | -$0.44 10-Q · filed 2016-08-11 | -$0.11 10-Q · filed 2015-08-14 | $2.07 derived: net income ÷ weighted average shares · filed 2016-12-14 | ||
| 2015-03-31 | -$0.12 10-Q · filed 2016-05-11 | -$0.03 10-Q · filed 2015-05-14 | -$0.18 10-Q · filed 2016-05-11 | -$0.05 10-Q · filed 2015-05-14 | $0.67 derived: net income ÷ weighted average shares · filed 2016-12-14 | $5.29 derived: net income ÷ weighted average shares · filed 2016-12-14 | ||
| 2014-12-31 | -$0.06 10-Q · filed 2016-02-08 | -$0.02 10-Q · filed 2015-02-17 | $0.29 derived: net income ÷ weighted average shares · filed 2016-12-14 | $1.30 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$3.04 derived: net income ÷ weighted average shares · filed 2016-12-14 | |||
| 2014-09-30 | $0.11 derived: net income ÷ weighted average shares · filed 2016-12-14 | $0.51 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$18.17 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$1.02 10-K · filed 2016-12-14 | -$0.30 10-K · filed 2014-12-29 | |||
| 2014-06-30 | -$0.03 10-Q · filed 2015-08-14 | -$0.05 derived: net income ÷ weighted average shares · filed 2015-08-14 | -$0.04 10-Q · filed 2015-08-14 | -$0.06 10-Q · filed 2014-08-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2015-08-14 | |||
| 2014-03-31 | -$0.03 10-Q · filed 2015-05-14 | -$0.04 10-Q · filed 2015-05-14 | -$0.09 derived: net income ÷ weighted average shares · filed 2015-05-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2015-05-14 | ||||
| 2013-12-31 | -$0.01 10-Q · filed 2015-02-17 | -$0.07 derived: net income ÷ weighted average shares · filed 2015-02-17 | -$0.08 derived: net income ÷ weighted average shares · filed 2015-02-17 | -$0.08 derived: net income ÷ weighted average shares · filed 2015-02-17 | ||||
| 2013-09-30 | -$0.08 derived: net income ÷ weighted average shares · filed 2014-12-29 | -$0.09 derived: net income ÷ weighted average shares · filed 2014-12-29 | -$0.10 derived: net income ÷ weighted average shares · filed 2014-12-29 | -$0.12 10-K · filed 2014-12-29 | ||||
| 2013-06-30 | -$0.01 10-Q · filed 2014-08-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2014-08-13 | -$0.02 10-Q · filed 2014-08-13 | -$0.05 derived: net income ÷ weighted average shares · filed 2014-08-13 | ||||
| 2013-03-31 | $0.00 10-Q/A · filed 2014-05-30 | -$0.02 10-Q/A · filed 2014-05-30 | -$0.04 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2014-05-30 | ||||
| 2012-12-31 | -$0.01 10-Q · filed 2014-02-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.23 derived: net income ÷ weighted average shares · filed 2014-05-30 | ||||
| 2012-09-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.18 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.29 10-K · filed 2013-12-30 | ||||
| 2012-06-30 | -$0.16 10-Q · filed 2013-08-14 | -$0.20 derived: net income ÷ weighted average shares · filed 2013-08-14 | -$0.28 10-Q · filed 2013-08-14 | -$0.33 derived: net income ÷ weighted average shares · filed 2014-05-30 | ||||
| 2012-03-31 | -$0.03 10-Q · filed 2013-05-17 | -$0.11 10-Q · filed 2013-05-17 | -$0.17 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.23 derived: net income ÷ weighted average shares · filed 2014-05-30 | ||||
| 2011-12-31 | -$0.08 10-Q · filed 2013-02-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.20 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.28 derived: net income ÷ weighted average shares · filed 2014-05-30 | ||||
| 2011-09-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.12 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.20 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.29 10-K · filed 2012-12-31 | ||||
| 2011-06-30 | -$0.06 10-Q · filed 2012-08-17 | -$0.14 derived: net income ÷ weighted average shares · filed 2012-08-17 | -$0.24 10-Q · filed 2012-08-17 | -$0.34 derived: net income ÷ weighted average shares · filed 2014-05-30 | ||||
| 2011-03-31 | -$0.08 10-Q · filed 2012-05-15 | -$0.17 10-Q · filed 2012-05-15 | -$0.28 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.37 derived: net income ÷ weighted average shares · filed 2014-05-30 | ||||
| 2010-12-31 | -$0.08 10-Q · filed 2012-02-14 | -$0.20 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.29 derived: net income ÷ weighted average shares · filed 2014-05-30 | |||||
| 2010-09-30 | -$0.12 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.22 derived: net income ÷ weighted average shares · filed 2014-05-30 | -$0.41 10-K · filed 2011-12-22 | |||||
| 2010-06-30 | -$0.09 10-Q · filed 2011-08-12 | -$0.28 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |